169 related articles for article (PubMed ID: 36545225)
1. Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma.
Tsai TY; Kao HK; Huang Y; Chang YT; Young CK; Hung SY; Chang YS; Yu JS; Chang KP
Cancer Manag Res; 2022; 14():3459-3468. PubMed ID: 36545225
[TBL] [Abstract][Full Text] [Related]
2. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer.
Chang YT; Chu LJ; Liu YC; Chen CJ; Wu SF; Chen CH; Chang IY; Wang JS; Wu TY; Dash S; Chiang WF; Chiu SF; Gou SB; Chien CY; Chang KP; Yu JS
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823758
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Serum Levels of Matrix MetalloProteinase-9 (MMP-9) in Oral Squamous Cell Carcinoma and Its Clinicopathological Correlation.
Benitha G; Ramani P; Jayaraman S; R A; Ramalingam K; Krishnan M
Cureus; 2023 Feb; 15(2):e34954. PubMed ID: 36938194
[TBL] [Abstract][Full Text] [Related]
4. Comparison between a novel salivary marker and several clinical prognosticators in oral cavity cancer.
Lee YC; Lee LY; Huang Y; Kao HK; Chang YT; Hung SY; Lu CY; Chang YS; Yu JS; Chang KP
Laryngoscope Investig Otolaryngol; 2023 Dec; 8(6):1547-1556. PubMed ID: 38130271
[TBL] [Abstract][Full Text] [Related]
5. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
6. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA.
Pazhani J; Chanthu K; Jayaraman S; Varun BR
J Oral Maxillofac Pathol; 2023; 27(4):649-654. PubMed ID: 38304520
[TBL] [Abstract][Full Text] [Related]
8. High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
Hsin CH; Chen MK; Tang CH; Lin HP; Chou MY; Lin CW; Yang SF
PLoS One; 2014; 9(11):e113129. PubMed ID: 25423087
[TBL] [Abstract][Full Text] [Related]
9. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
[TBL] [Abstract][Full Text] [Related]
10. Serum melatonin is inversely associated with matrix metalloproteinase-9 in oral squamous cell carcinoma.
Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Pantea-Stoian A; Nitipir C; Gheorghe DC
Oncol Lett; 2020 Apr; 19(4):3011-3020. PubMed ID: 32218858
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
Cai M; Zheng Z; Bai Z; Ouyang K; Wu Q; Xu S; Huang L; Jiang Y; Wang L; Gao J; Pathak JL; Wu L
BMC Cancer; 2022 May; 22(1):530. PubMed ID: 35545767
[TBL] [Abstract][Full Text] [Related]
12. Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma.
Yeh CC; Kao HK; Huang Y; Tsai TY; Young CK; Hung SY; Lu CY; Chang KP
Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612318
[TBL] [Abstract][Full Text] [Related]
13. [Expression levels of MMP-14, ING4 and HIF-1α in 60 patients with oral squamous cell carcinoma and their clinical significance].
Fu ZY; Tao F
Shanghai Kou Qiang Yi Xue; 2020 Dec; 29(6):642-646. PubMed ID: 33778834
[TBL] [Abstract][Full Text] [Related]
14. Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma.
Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Umeda M; Nemoto TK; Kurita H
Pathol Oncol Res; 2016 Jul; 22(3):625-32. PubMed ID: 26874697
[TBL] [Abstract][Full Text] [Related]
15. MMP-11 promoted the oral cancer migration and Fak/Src activation.
Hsin CH; Chou YE; Yang SF; Su SC; Chuang YT; Lin SH; Lin CW
Oncotarget; 2017 May; 8(20):32783-32793. PubMed ID: 28427180
[TBL] [Abstract][Full Text] [Related]
16. Low expression of RECK in oral squamous cell carcinoma patients induces a shorter survival rate through an imbalance of RECK/MMPs.
Yuan J; Li W; Zhu J; Deng S; Tao X
Int J Clin Exp Pathol; 2020; 13(3):501-508. PubMed ID: 32269688
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C
Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474
[TBL] [Abstract][Full Text] [Related]
18. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.
Silva SD; Alaoui-Jamali MA; Hier M; Soares FA; Graner E; Kowalski LP
Clin Exp Metastasis; 2014 Mar; 31(3):307-16. PubMed ID: 24338375
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-3 sponges Tiam1 to manipulate MMP-7 activity through β-catenin signaling in oral squamous cell carcinoma.
Guo H; Ji Y; Zhang B; Huang X
Med Oncol; 2022 Jul; 39(10):154. PubMed ID: 35852664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
